Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression
Chuqian Zheng, Min Liu, Yanping Ge, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 111
FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
Meng Xie, Zhuoying Lin, Xiaoyu Ji, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 109-125
Open Access | Times Cited: 86
Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis
Rui Li, Xuefei Liu, Xudong Huang, et al.
Gut (2023), pp. gutjnl-330243
Open Access | Times Cited: 19
ETS transcription factors: Multifaceted players from cancer progression to tumor immunity
Yufei Wang, Zhao Huang, Mengyu Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188872-188872
Closed Access | Times Cited: 15
An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
Guizhen Zhang, Zhu Weiwei, Yun Wang, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 14
Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer
Weisong Li, Kai Zhang, Wenjun Wang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression
Junyou Zhang, Qilin Wang, Sihan Qi, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application
Yang Chen, Rui Liang, Yong Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets
Xuejin Lu, Meizi Zhu, Xueliang Pei, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
IL35 modulates HBV-related HCC progression via IL6-STAT3 signaling
Mingran Zhou, Yunhong Xia, Shuomin Wang
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A narrative review of epigenetic marker in H3K27ac and its emerging potential as a therapeutic target in cancer
Meizi Zhu, Xuejin Lu, Danhong Wang, et al.
Epigenomics (2025), pp. 1-17
Closed Access
Insights into the Role of Oxidative Stress in Hepatocellular Carcinoma Development
Yuanyuan Li, Yang Yu, Lei Yang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 11, pp. 286-286
Open Access | Times Cited: 12
Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis
Fei Wang, Hongxiao Song, Fengchao Xu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
HBx downregulated decorin and decorin‐derived peptides inhibit the proliferation and tumorigenicity of hepatocellular carcinoma cells
Yong Li, Lipeng Gan, Lü Min, et al.
The FASEB Journal (2023) Vol. 37, Iss. 4
Closed Access | Times Cited: 7
Biological effect of ETV4 and the underlying mechanism of its regulatory effect on epithelial‑mesenchymal transition in intrahepatic cholangiocarcinoma cells
Li Liu, Yong Feng, Xuelian Xiang, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 2
ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-β signaling
Fangfeng Liu, Qianchang Wang, Zhengjian Wang, et al.
Translational Oncology (2024) Vol. 47, pp. 102035-102035
Open Access | Times Cited: 2
Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein
Xiaocui Li, Delong Kong, Wei Hu, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression
Hongmeng Su, Shihui Shu, Wenqing Tang, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 684, pp. 149137-149137
Closed Access | Times Cited: 5
Nuclear respiratory factor 1 regulates super enhancer-controlled SPIDR to protect hepatocellular carcinoma cells from oxidative stress
Baowang Liu, Jian Dou, Jinglin Cao
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma
Ping‐Kun Zhou, Wei Yao, Lijuan Liu, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1757-1778
Closed Access | Times Cited: 1
Study on the Mechanism of FOXA2 Activation on Glutathione Metabolic Reprogramming Mediated by ETV4 Transcription to Facilitate Colorectal Cancer Malignant Progression
Xiangcheng Zhang, Yali He, Jiayue Shen, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma
Xinhao Peng, Ying Shi, Biqin Zhang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Closed Access | Times Cited: 4
The role of ETV4 in HCC: How transcription factors can inform immunotherapy combination treatments
Amanda J. Craig, Maruhen Amir Datsch Silveira
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 19-21
Open Access | Times Cited: 2
ETV4 facilitates proliferation, migration, and invasion of liver cancer by mediating TGF-β signal transduction through activation of B3GNT3
Zhongcheng Zhou, Bin Wu, Jing Chen, et al.
Genes & Genomics (2023) Vol. 45, Iss. 11, pp. 1433-1443
Closed Access | Times Cited: 2
Comprehensive Analysis of the Mechanism of Anoikis in Hepatocellular Carcinoma
Dongqian Li, Qian Bao, Shiqi Ren, et al.
Genetics Research (2024) Vol. 2024, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top